Clinical Trial Results:
A single agent Phase II study of depsipeptide (FK228) in the treatment of Cutaneous T-cell lymphoma
Summary
|
|
EudraCT number |
2004-001012-32 |
Trial protocol |
DE GB AT |
Global completion date |
12 Mar 2008
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v2(current) |
This version publication date |
16 Oct 2016
|
First version publication date |
12 May 2016
|
Other versions |
v1 |
Version creation reason |
|
Summary report(s) |
CSR Synopsis Final Results From a Multicenter, International, Pivotal Study of Romidepsin in Refractory Cutaneous T-Cell Lymphoma |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.